Describe the context and need for advanced training in medical management of CBRN casualties |
|
|
|
|
|
|
|
Apply the CRESS algorithm to identify toxidromes (consciousness, respirations, eyes, secretions, skin) |
|
|
|
|
|
|
|
Identify opportunities to treat chemical, biological, radiological, and nuclear (CBRN) casualties through the LADMER (liberation, absorption, distribution, metabolism, elimination, response) approach |
|
|
|
|
|
|
|
Recognize useful reference materials for management of CBRN casualties |
|
|
|
|
|
|
|
Describe nerve agent pathophysiology from molecular to patient level |
|
|
|
|
|
|
|
Manage nerve agent casualties at the Role 3/4, and intensive care setting |
|
|
|
|
|
|
|
Recognize novel and contingency treatments for cholinergic crisis |
|
|
|
|
|
|
|
Integrate NATO-Ally formularies to manage nerve agent casualties |
|
|
|
|
|
|
|
Prepare for management of multiple simultaneous severe nerve agent casualties |
|
|
|
|
|
|
|
Describe fundamental principles for identifying and treating a casualty with a metabolic agent intoxication |
|
|
|
|
|
|
|
Describe the pharmacokinetic properties of naloxone, including its absorption, distribution, metabolism, and elimination |
|
|
|
|
|
|
|
Identify an appropriate antidote for a person poisoned with thallium or arsenic describing its mechanism of action and administration protocol |
|
|
|
|
|
|
|
Select the appropriate pharmacological agent to manage agitation, autonomic activity, and prevent or treat seizures, given a case involving a patient exposed to anticholinergic agents |
|
|
|
|
|
|
|